Inventor · disambiguated record
John D. Hood
Also filed as: COLE MARTIN · HOOD JOHN D · HOOD JOHN DICK · HOOD JOHN F
23 granted patents·10 pending applications·562 citations·filing 1976–2010
95Inventor score
Top patents by PatentIndex Score
33 records- 0197US7528143B2Bi-aryl meta-pyrimidine inhibitors of kinasesTARGEGEN INC·Filed 2006·Granted May 5, 2009·220 cites·44 claims
- 0295US8133900B2Use of bi-aryl meta-pyrimidine inhibitors of kinasesHOOD JOHN D·Filed 2008·Granted Mar 13, 2012·88 cites·26 claims
- 0395US7825246B2Bi-aryl meta-pyrimidine inhibitors of kinasesTARGEGEN INC·Filed 2007·Granted Nov 2, 2010·40 cites·9 claims
- 0494US8138199B2Use of bi-aryl meta-pyrimidine inhibitors of kinasesNORONHA GLENN·Filed 2008·Granted Mar 20, 2012·45 cites·31 claims
- 0592US8604042B2Bi-aryl meta-pyrimidine inhibitors of kinasesNORONHA GLENN·Filed 2010·Granted Dec 10, 2013·29 cites·5 claims
- 0691US7208493B2Vasculostatic agents and methods of use thereofTARGEGEN INC·Filed 2003·Granted Apr 24, 2007·68 cites·9 claims
- 0785US7456176B2Benzotriazine inhibitors of kinasesTARGEGEN INC·Filed 2005·Granted Nov 25, 2008·11 cites·34 claims
- 0871US4162304AStreptomycetal antibioticBEECHAM GROUP LTD·Filed 1976·Granted Jul 24, 1979·7 cites·20 claims
- 0967US4189473AAntibiotic MM 13902BEECHAM GROUP LTD·Filed 1976·Granted Feb 19, 1980·18 cites·14 claims
- 1066US4172129AAntibioticsBEECHAM GROUP LTD·Filed 1976·Granted Oct 23, 1979·5 cites·9 claims
- 1161US2010278811A1Vasculostatic agents and methods of use thereofTARGEGEN INC·Filed 2009·Application pending·0 cites
- 1259US2003187713A1Response potential modelFiled 2003·Application pending·0 cites
- 1356US2007161645A1Thiazole inhibitors targeting resistant kinase mutationsTARGEGEN INC·Filed 2006·Application pending·0 cites
- 1455US2005282814A1Vasculostatic agents and methods of use thereofTARGEGEN INC·Filed 2005·Application pending·0 cites
- 1554US2007208019A1Vasculostatic agents and methods of use thereofTARGEGEN INC·Filed 2007·Application pending·0 cites
- 1654US2009275569A1Benzotriazine Inhibitors of KinasesGONG XIANCHANG·Filed 2008·Application pending·0 cites
- 1751US4146610AAntibiotics mm13902BEECHAM GROUP LTD·Filed 1976·Granted Mar 27, 1979·8 cites·22 claims
- 1851US2011269721A1Methods of treating thalassemiaTARGEGEN INC·Filed 2009·Application pending·0 cites
- 1951US2007149508A1Six membered heteroaromatic inhibitors targeting resistant kinase mutationsTARGEGEN INC·Filed 2006·Application pending·0 cites
- 2050US5536715ACombinations of anthelmintically active agentsPFIZER·Filed 1995·Granted Jul 16, 1996·9 cites·11 claims
- 2148US4181716AAntibioticsBEECHAM GROUP LTD·Filed 1976·Granted Jan 1, 1980·2 cites·8 claims
- 2246US2010330030A1Vasculostatic Agents and Methods of Use ThereofTARGEGEN INC·Filed 2010·Application pending·0 cites
- 2345US4113856AAntibiotic mm 13902BEECHAM GROUP LTD·Filed 1976·Granted Sep 12, 1978·5 cites·10 claims
- 2443US8481536B2Benzotriazine inhibitors of kinasesGONG XIANCHANG·Filed 2010·Granted Jul 9, 2013·0 cites·5 claims
- 2541US2006247250A1Pyrimidine inhibitors of kinasesTARGEGEN INC·Filed 2006·Application pending·0 cites
- 2640US4203973AAntibioticsBEECHAM GROUP LTD·Filed 1978·Granted May 20, 1980·1 cites·26 claims
- 2738US4163051AStreptomycetal antibioticBEECHAM GROUP LTD·Filed 1976·Granted Jul 31, 1979·1 cites·9 claims
- 2837US4206202AAntibioticsBEECHAM GROUP LTD·Filed 1978·Granted Jun 3, 1980·2 cites·26 claims
- 2937US4205067AAntibioticsBEECHAM GROUP LTD·Filed 1977·Granted May 27, 1980·2 cites·32 claims
- 3034US4235882AAntibiotic MM 4550ABEECHAM GROUP LTD·Filed 1976·Granted Nov 25, 1980·1 cites·20 claims
- 3130US5643886AAvermectins and milbemycins to treat parasitic infestations in dogsPFIZER·Filed 1991·Granted Jul 1, 1997·0 cites·8 claims
- 3229US4261977AStreptomycetal antibioticBEECHAM GROUP LTD·Filed 1978·Granted Apr 14, 1981·0 cites·20 claims
- 3329US4179498AStreptomycetal antibioticBEECHAM GROUP LTD·Filed 1976·Granted Dec 18, 1979·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when John D. Hood files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →